YBGJ Stock Chart & Stats
$0.01
>-$0.01(-6.04%)
At close: 4:00 PM EDT
$0.01
>-$0.01(-6.04%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.05
Previous CloseN/A
Volume2.00K
Average Volume (3M)1.51K
Market Cap
$2.39M
Enterprise Value$867.54K
Total Cash (Recent Filing)$10.38K
Total Debt (Recent Filing)$39.22K
Price to Earnings (P/E)―
Beta-0.56
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding170,416,340
10 Day Avg. Volume4,514
30 Day Avg. Volume1,508
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-0.89
Price to Sales (P/S)12.88
P/FCF Ratio-2.05
Enterprise Value/Market Cap0.36
Enterprise Value/Revenue6.46
Enterprise Value/Gross Profit40.78
Enterprise Value/Ebitda-0.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Yubo International Biotech News
YBGJ FAQ
What was Yubo International Biotech’s price range in the past 12 months?
Yubo International Biotech lowest stock price was <$0.01 and its highest was $0.05 in the past 12 months.
What is Yubo International Biotech’s market cap?
Yubo International Biotech’s market cap is $2.39M.
When is Yubo International Biotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Yubo International Biotech’s earnings last quarter?
Currently, no data Available
Is Yubo International Biotech overvalued?
According to Wall Street analysts Yubo International Biotech’s price is currently Overvalued.
Does Yubo International Biotech pay dividends?
Yubo International Biotech does not currently pay dividends.
What is Yubo International Biotech’s EPS estimate?
Yubo International Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yubo International Biotech have?
Yubo International Biotech has 170,416,340 shares outstanding.
What happened to Yubo International Biotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Yubo International Biotech?
Currently, no hedge funds are holding shares in YBGJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yubo International Biotech
Yubo International Biotech Limited, operating through its various subsidiaries, primarily dedicates its efforts to the research, development, and practical application of endometrial stem cells. Beyond this core focus, the company also provides a diverse range of products, including solutions for respiratory health, skincare and hair care formulations, nutritious beverages, and personal care items tailored for both men and women. Furthermore, it delivers specialized stem cell services, such as cellular analysis and comprehensive health management consulting, all offered under the VIVCELL brand. The company's headquarters are located in Beijing, China.
Technical Analysis
Ownership Overview
63.23% Insiders
―
Mutual Funds
― Other Institutional Investors
36.77% Public Companies and
Individual Investors